The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership for Molecular Medicine. DANDRITE was established by the Lundbeck Foundation and Aarhus University in 2013 and performs basic and translational research in brain and the nervous system. 

DANDRITE is an interdisciplinary research centre affiliated with two faculties at Aarhus University, the Faculty of Health and the Faculty of Science and Technology. The centre has ties to Aarhus University Hospital.

The director of DANDRITE is Professor Poul Nissen, who together with Professor Anders Nykjær and Professor Poul Henning Jensen represents the core research groups. In accordance with the EMBL tradition, DANDRITE will recruit five group leaders from across the globe to establish a thriving, cutting-edge research environment that brings in a unique range of neuroscience research ideas and methodologies. DANDRITE also hosts visiting scientists and collaborates with the to the Danish research community through associate research programs.

The focus of DANDRITE research will be on molecular mechanisms that explain physiological manifestations of cellular communication networks in brain circuitries, and how these are affected in neurological and psychiatric disorders. Furthermore, translational research aiming for new strategies in diagnostic and clinical practice, drug discovery and spin-out activities will be encouraged. For further information, see Research aims & groups.

The main features of DANDRITE are:

  • Cutting-edge molecular and translational neuroscience in an open and international research environment
  • Membership in the Nordic EMBL Partnership for Molecular Medicine with nodes in Oslo, Umeå, Helsinki and Aarhus
  • Talent development through the advancement of outstanding young group leaders and training of PhD students and postdocs
  • Close collaboration with clinical research and the pharmaceutical industry and stimulation of new biotech companies

The Nordic EMBL Partnership for Molecular Medicine

The Nordic European Molecular Biology Laboratories Partnership for Molecular Medicine was established in 2007 with partner nodes in Sweden, Finland and Norway, each with their own academic focus and independent research profile. Opened in 2013, the Danish Research Institute of Translational Neuroscience (DANDRITE) joins the Nordic EMBL Partnership. The partnership facilitates scientific collaboration and access to scientific infrastructure, including databases, facilities and instrumentation, as well as services and training activities provided by the partners.

European Molecular Biology Laboratory (EMBL)

  • One of the world’s leading research institutions, and Europe’s flagship laboratory for the life sciences
  • Intergovernmental organization comprised of 21 member states and one associate member state - Australia. The headquarters are in Heidelberg (Germany), with outstations in Hamburg (Germany), Grenoble (France), Monterotondo (Italy), and the EMBL-European Bioinformatics Institute (EBI) in Hinxton (UK)

Laboratory for Molecular Infection Medicine Sweden (MIMS) 

  • Hosted by Umeå University and closely connected to the Norrlands University Hospital
  • Builds on Sweden’s strength in microbial pathogenicity and molecular infection medicine

Norwegian Centre for Molecular Medicine (NCMM)

  • Hosted by the University of Oslo in partnership with the Regional Health Authority South-East, and with links to the other universities and regional health authorities in Norway
  • Builds on Norway’s strength in molecular mechanisms of disease

Finnish Institute for Molecular Medicine (FIMM) 

  • A joint venture of the University of Helsinki, the Hospital District of Helsinki and Uusimaa, and the National Public Health Institute
  • Builds on Finland’s strength in integrated clinical and basic biomedical research coupled with population-wide genetic epidemiology and well-characterised databases

The Danish Research Institute of Translational Neuroscience (DANDRITE)

  • A cooperation of the Lundbeck Foundation and Aarhus University and closely connected with the Aarhus University Hospital
  • Builds on Denmark’s strength in molecular and translational neuroscience